CODEXIS, INC. (CDXS): restructuring charge — Codexis appoints Alison Moore CEO, cuts 24% workforce, signs $37.8M Merck deal; Q3 net loss $19.6M

CODEXIS, INC.

Alison Moore appointed President and CEO effective Nov 7, 2025; Stephen Dilly becomes Executive Chairman.
Workforce reduced by 46 positions (~24%); expects $3.5M expense in Q4 2025, substantially completed by Jan 2026.
Signed $37.8M Supply Assurance Agreement with Merck; cash anticipated by year-end 2025.
Q3 2025 revenue $8.6M (down from $12.8M YoY); net loss $19.6M ($0.22/share).
Cash and investments $58.7M as of Sept 30, 2025; cash runway extended through 2027.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

CODEXIS, INC. announced a restructuring with charges of approximately $3.5 million affecting ECO Synthesis platform (approximately 24%).

Type: restructuring
Charge: approximately $3.5 million
Affected area: ECO Synthesis platform
Headcount: approximately 24%

Exact text from the filing

benefits to impacted employees, as well as the payment of other expenses such as related tax costs, will result in the recognition of an additional expense of approximately $3.5 million. The Company anticipates this expense will be recognized in the fourth quarter of 2025 and paid primarily during the same period. The Company expects the workforce reduction to

View on SEC.gov

Browse all restructurings & charges →

CODEXIS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-25-269716

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.